140 related articles for article (PubMed ID: 29534999)
21. Role of intracellular signaling events in ADP-induced platelet aggregation.
Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
[TBL] [Abstract][Full Text] [Related]
22. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions.
Koessler J; Schwarz M; Weber K; Etzel J; Koessler A; Boeck M; Kobsar A
PLoS One; 2017; 12(11):e0188193. PubMed ID: 29155852
[TBL] [Abstract][Full Text] [Related]
23. Potassium 2-(1-hydroxypentyl)-benzoate inhibits ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathways.
Yang H; Xu S; Li J; Wang L; Wang X
Naunyn Schmiedebergs Arch Pharmacol; 2015 Sep; 388(9):983-90. PubMed ID: 25787305
[TBL] [Abstract][Full Text] [Related]
24. Nucleotide P2Y13-stimulated phosphorylation of CREB is required for ADP-induced proliferation of late developing retinal glial progenitors in culture.
Jacques FJ; Silva TM; da Silva FE; Ornelas IM; Ventura ALM
Cell Signal; 2017 Jul; 35():95-106. PubMed ID: 28347874
[TBL] [Abstract][Full Text] [Related]
25. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
[TBL] [Abstract][Full Text] [Related]
27. Calmodulin interacts with the platelet ADP receptor P2Y1.
Arthur JF; Shen Y; Mu FT; Leon C; Gachet C; Berndt MC; Andrews RK
Biochem J; 2006 Sep; 398(3):339-43. PubMed ID: 16848759
[TBL] [Abstract][Full Text] [Related]
28. The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor.
Tournoij E; Koekman CA; Du VX; Roest M; Ruijtenbeek R; Moll FL; Akkerman JW
Platelets; 2012; 23(8):617-25. PubMed ID: 22273509
[TBL] [Abstract][Full Text] [Related]
29. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
Schweigel H; Geiger J; Beck F; Buhs S; Gerull H; Walter U; Sickmann A; Nollau P
Proteomics; 2013 Mar; 13(6):1016-27. PubMed ID: 23322602
[TBL] [Abstract][Full Text] [Related]
30. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
[TBL] [Abstract][Full Text] [Related]
31. Role of P2Y1 purinoceptor in ADP-induced platelet activation.
Savi P; Beauverger P; Labouret C; Delfaud M; Salel V; Kaghad M; Herbert JM
FEBS Lett; 1998 Feb; 422(3):291-5. PubMed ID: 9498802
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y 1 and P2Y 12 Receptors.
Wu CC; Tsai FM; Chen ML; Wu S; Lee MC; Tsai TC; Wang LK; Wang CH
Biomed Res Int; 2016; 2016():2532371. PubMed ID: 27069920
[TBL] [Abstract][Full Text] [Related]
33. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
34. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.
Jin J; Kunapuli SP
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8070-4. PubMed ID: 9653141
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Storey RF; May JA; Heptinstall S
Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
[TBL] [Abstract][Full Text] [Related]
36. Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.
Ruel R; L'Heureux A; Thibeault C; Lapointe P; Martel A; Qiao JX; Hua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Wexler RR; Rehfuss R; Lam PY
Bioorg Med Chem Lett; 2013 Dec; 23(24):6825-8. PubMed ID: 24269480
[TBL] [Abstract][Full Text] [Related]
37. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.
Garcia A; Kim S; Bhavaraju K; Schoenwaelder SM; Kunapuli SP
Biochem J; 2010 Jul; 429(2):369-77. PubMed ID: 20441566
[TBL] [Abstract][Full Text] [Related]
38. Pennogenin tetraglycoside stimulates secretion-dependent activation of rat platelets: evidence for critical roles of adenosine diphosphate receptor signal pathways.
Cong Y; Liu X; Kang L; Yu Z; Zhao Z; Li J; Ma B; Cong Y
Thromb Res; 2012 May; 129(5):e209-16. PubMed ID: 22401797
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
40. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
